| Dr James Randal Trimm, MD | |
|
100 Pilot Medical Drive, Suite 300, Birmingham, AL 35235-3412 | |
| (205) 856-2284 | |
| (205) 815-4777 |
| Full Name | Dr James Randal Trimm |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 24 Years |
| Location | 100 Pilot Medical Drive, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487790481 | NPI | - | NPPES |
| 2501415 | Other | AL | UNITED HEALTHCARE |
| 51540188 | Other | AL | BCBS |
| 9911768 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 24518 (Alabama) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 24518 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Vincent's East | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Birmingham Heart Clinic, Pc | 6901822444 | 21 |
News Archive
Despite an assessment in 2007 indicating that night shift work was probably carcinogenic, data from three new studies and from a review of currently available evidence, published in the Journal of the National Cancer Institute, indicate that night shift work has little or no effect on breast cancer incidence.
A team from the University of Liège has discovered a new crosstalk between the migrating inhibitory interneurons and the stem cells that generate the excitatory neurons.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Shire plc, the global specialty biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion on the marketing authorisation for VPRIV (velaglucerase alfa), the company's enzyme replacement therapy for the treatment of type 1 Gaucher disease.
› Verified 7 days ago
| Entity Name | Birmingham Heart Clinic, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508932583 PECOS PAC ID: 6901822444 Enrollment ID: O20051024000428 |
News Archive
Despite an assessment in 2007 indicating that night shift work was probably carcinogenic, data from three new studies and from a review of currently available evidence, published in the Journal of the National Cancer Institute, indicate that night shift work has little or no effect on breast cancer incidence.
A team from the University of Liège has discovered a new crosstalk between the migrating inhibitory interneurons and the stem cells that generate the excitatory neurons.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Shire plc, the global specialty biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion on the marketing authorisation for VPRIV (velaglucerase alfa), the company's enzyme replacement therapy for the treatment of type 1 Gaucher disease.
› Verified 7 days ago
| Entity Name | St Vincents Ambulatory Healthcare Network Llc |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1033646823 PECOS PAC ID: 1355608456 Enrollment ID: O20180626000597 |
News Archive
Despite an assessment in 2007 indicating that night shift work was probably carcinogenic, data from three new studies and from a review of currently available evidence, published in the Journal of the National Cancer Institute, indicate that night shift work has little or no effect on breast cancer incidence.
A team from the University of Liège has discovered a new crosstalk between the migrating inhibitory interneurons and the stem cells that generate the excitatory neurons.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Shire plc, the global specialty biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion on the marketing authorisation for VPRIV (velaglucerase alfa), the company's enzyme replacement therapy for the treatment of type 1 Gaucher disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Randal Trimm, MD 100 Pilot Medical Drive, Suite 300, Birmingham, AL 35235-3412 Ph: (205) 856-2284 | Dr James Randal Trimm, MD 100 Pilot Medical Drive, Suite 300, Birmingham, AL 35235-3412 Ph: (205) 856-2284 |
News Archive
Despite an assessment in 2007 indicating that night shift work was probably carcinogenic, data from three new studies and from a review of currently available evidence, published in the Journal of the National Cancer Institute, indicate that night shift work has little or no effect on breast cancer incidence.
A team from the University of Liège has discovered a new crosstalk between the migrating inhibitory interneurons and the stem cells that generate the excitatory neurons.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Shire plc, the global specialty biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion on the marketing authorisation for VPRIV (velaglucerase alfa), the company's enzyme replacement therapy for the treatment of type 1 Gaucher disease.
› Verified 7 days ago
Juan Mario Bernal, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |